South Africa Says AIDS Drugs Available Despite US Funding Cut
South Africa 's government said its HIV-AIDS treatment program is fully funded for the current financial year despite the withdrawal of support from the US, and all patients should continue to receive their medication.
About 7.8 million South Africans, or almost 13% of the population, live with the virus that causes AIDS — the world's biggest HIV epidemic. About 17% of the funding for the country's HIV-AIDS program has come from America's Presidential Emergency Funding for Aids Relief, or Pepfar, but President Donald Trump suspended that program in January, meaning 7.5 billion rand ($414 million) needs to be found to plug the gap.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Deadline for spring COVID-19 booster approaching - who can get it
The NHS in West Yorkshire has encouraged eligible individuals to get a COVID-19 booster before the current vaccination campaign ends on Tuesday, June 17. The booster is being offered to people aged 75 and over, residents in care homes for older adults, and anyone aged six months and over with a weakened immune system. A spokesperson said: "This includes people who have or are receiving treatment for conditions such as diabetes, blood cancer, organ transplant, HIV, or those taking medicines that weaken the immune system, such as high-dose steroids or immunosuppressants following cancer treatment." Dr James Thomas, medical director for the West Yorkshire Integrated Care Board and a Leeds-based GP, said: "Vaccination remains the best way to protect yourself and those around you from the serious effects of COVID-19. "The virus hasn't gone away, and those most at risk can still become seriously unwell. "If you're eligible for the spring booster, please don't miss this opportunity – book now or visit a walk-in pharmacy before June 17." Appointments can be booked through the NHS App, online at or by calling 119. Some walk-in pharmacies are also available across West Yorkshire. A full definition of immunosuppression can be found in Chapter 14a (table 3) of the Green Book:
Yahoo
44 minutes ago
- Yahoo
Palantir and TeleTracking Team Up to Enhance Healthcare Operations Using AI-Driven Insights
TeleTracking Technologies, a leading provider of healthcare operations platforms, has teamed up with Palantir Technologies Inc. (NASDAQ:PLTR), known for its expertise in artificial intelligence systems. The two companies have formed a strategic partnership with the goal of transforming how hospitals and health systems make operational decisions, ultimately creating long-term value for healthcare providers around the world. The collaboration will integrate TeleTracking's Operations IQ platform with Palantir Technologies Inc. (NASDAQ:PLTR)'s AI-driven tools, including Foundry and AIP. This combined solution is expected to equip hospitals with near real-time, actionable insights to improve staffing efficiency, speed up decision-making, and ensure that patient needs remain the top priority. As healthcare systems continue to face increasing demands to enhance capacity and coordination without expanding their physical footprint, this partnership represents a significant step forward. By bringing together TeleTracking's operational strengths and Palantir Technologies Inc. (NASDAQ:PLTR)'s cutting-edge technology, the two aim to usher in a new era of intelligent, scalable, and efficient healthcare delivery. Alex Karp, CEO at Palantir Technologies Inc. (NASDAQ:PLTR) made the following comment: 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach, helping to streamline operations allowing for increased focus on providing the best level of care.' Palantir Technologies Inc. (NASDAQ:PLTR) is an American publicly traded company that focuses on developing software platforms designed for analyzing large volumes of data. While we acknowledge the potential of PLTR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
An OpenAI exec says she was diagnosed with breast cancer and that ChatGPT has helped her navigate it
Kate Rouch, OpenAI's chief marketing officer, said she was diagnosed with breast cancer. Rouch said she is expected to make a full recovery and urged other women to prioritize their health. She said she leaned on OpenAI's ChatGPT to navigate her treatment. Kate Rouch, the chief marketing officer at OpenAI, shared on Friday that she was diagnosed with invasive breast cancer weeks after assuming the role, which she called her "dream job," in December. In a thread posted on X, Rouch said she was sharing her story to help other women, adding, "We can't control what happens to us--but we can choose how we face it. My biggest lesson: no one fights alone." Prior to joining OpenAI as the company's first CMO, Rouch was CMO at Coinbase and, before that, spent over a decade at Meta, including as vice president, global head of brand and product marketing. Rouch said she started treatment right around the Super Bowl in February, when OpenAI aired its first-ever ad, and that she has since gone through 13 rounds of chemotherapy while leading OpenAI's marketing team. She wrote that she is expected to make a full recovery. "It has been the hardest season of life — for me, for my husband, and for our two young children," Rouch said, adding she has been supported by OpenAI "at every step." "Silicon Valley can be brutal and transactional. And yet — I've never felt more held," she said, adding that "people showed up in incredible and unexpected ways." Rouch also said OpenAI's ChatGPT has helped her navigate her diagnosis and treatment, including by explaining cancer in a way that is age-appropriate for her kids, helping her manage the side effects of chemo, and creating custom meditations. "Experiencing our work as a patient has made OpenAI's mission feel more personal and important," she said. Rouch said she was sharing her story to encourage other women to "prioritize their health over the demands of families and jobs." "A routine exam saved my life. It could save yours, too," she said. Business Insider reached out to OpenAI for comment. Kevin Weil, the chief product officer at OpenAI, expressed support for Rouch in a reply to her thread. "We love you @kate_rouch!" he wrote. "Proud of you for telling your story and for being so full of fight." Read the original article on Business Insider
